GEODE CAPITAL MANAGEMENT, LLC - NAUTILUS BIOTECHNOLOGY INC ownership

NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 76 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of NAUTILUS BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$3,206,442
-17.7%
1,014,567
+0.8%
0.00%
Q2 2023$3,895,023
+41.5%
1,006,466
+1.3%
0.00%
Q1 2023$2,752,510
+159096.6%
993,686
+3.4%
0.00%
Q4 2022$1,729
-99.9%
960,868
+0.6%
0.00%
Q3 2022$2,024,000
-20.8%
955,069
+0.5%
0.00%
Q2 2022$2,557,000
+12.0%
950,779
+80.7%
0.00%
Q1 2022$2,284,000
-11.0%
526,306
+6.3%
0.00%
Q4 2021$2,565,000
+8.3%
495,198
+28.3%
0.00%
Q3 2021$2,369,000
+258.9%
385,871
+490.0%
0.00%
Q2 2021$660,00065,3970.00%
Other shareholders
NAUTILUS BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Madrona Venture Group, LLC 6,020,770$30,663,0004.08%
Ally Bridge Group (NY) LLC 1,500,000$9,210,0002.71%
AMAZON COM INC 1,457,055$8,946,0001.82%
Affinity Asset Advisors, LLC 975,000$5,987,0001.51%
Tikvah Management LLC 708,540$4,350,436,0001.18%
Perceptive Advisors 8,911,151$54,714,0000.80%
Bain Capital Life Sciences Investors, LLC 2,000,000$12,280,0000.76%
HILLMAN CO 200,000$1,228,0000.43%
SPHERA FUNDS MANAGEMENT LTD. 800,000$4,912,0000.41%
RA Capital Management 2,436,430$14,960,0000.21%
View complete list of NAUTILUS BIOTECHNOLOGY INC shareholders